Go-to-Market Strategy & Forecasting for an AI-Driven Medical Imaging Company

A UK-based medical imaging start-up sought to understand the requirements for a successful U.S. go-to-market (GTM) strategy for an AI-informed osteoporosis diagnostic tool.

We began by assessing the US landscape for diagnostic imaging and osteoporosis. This included a review of the US market fundamentals, macro-environment, competition, key stakeholders, trends, payer landscape, and customer analysis. It also involved a customer assessment to prioritize target customers and optimal business models. Next, we conducted primary market research with a wide range of stakeholders to refine our understanding of the landscape and test potential value propositions for the company. Finally, we developed a 3-phase GTM strategy and roadmap. This included a multimodal revenue forecast and financial opportunity assessment based on three prioritized GTM scenarios to inform company expectations and aid in capital funding.

Our team identified the optimal US go-to-market strategy and helped guide the client on the journey.  Additionally, we developed a full revenue forecast and financial opportunity assessment that was used in capital raising presentations.